Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
NCT ID: NCT05283811
Last Updated: 2025-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
205 participants
INTERVENTIONAL
2021-06-01
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neural Basis of Cognition
NCT05132543
Navigation and Free Recall in Chronically Implanted Humans
NCT02781129
Neuronal Mechanisms of Human Episodic Memory
NCT04500119
Memory Retrieval and Encoding Investigated by Neural Stimulation
NCT04286776
Modulation of Emotion Perception in Humans Via Amygdala Stimulation
NCT05292183
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
FACTORIAL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Epilepsy Monitoring Unit
Patient's behavioral and neural activity via computer tasks and questionnaires are monitored in the Epilepsy Monitoring Unit
EMU
Patients are admitted to the Epilepsy Monitoring Unit for observation of seizure activity prior to further treatment
Neuropace RNS Device
Patients are implanted with RNS device to treat their seizure activity
NEUROPACE RNS SYSTEM
This device is indicated as a therapy in reducing the frequency of seizures in individuals
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NEUROPACE RNS SYSTEM
This device is indicated as a therapy in reducing the frequency of seizures in individuals
EMU
Patients are admitted to the Epilepsy Monitoring Unit for observation of seizure activity prior to further treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
10 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baylor College of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sameer Sheth
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Los Angeles
Los Angeles, California, United States
Baylor College of Medicine
Houston, Texas, United States
University of Utah
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nanthia Suthana
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H18112
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.